Texas Permanent School Fund Corp Has $17.84 Million Holdings in CME Group Inc. (NASDAQ:CME)

Texas Permanent School Fund Corp lifted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 0.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 82,876 shares of the financial services provider’s stock after purchasing an additional 285 shares during the period. Texas Permanent School Fund Corp’s holdings in CME Group were worth $17,842,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in CME Group by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock valued at $7,044,821,000 after purchasing an additional 215,044 shares in the last quarter. Capital World Investors increased its stake in CME Group by 8.7% in the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after buying an additional 1,172,575 shares during the last quarter. Capital International Investors increased its stake in CME Group by 0.4% in the 4th quarter. Capital International Investors now owns 12,739,369 shares of the financial services provider’s stock valued at $2,683,012,000 after buying an additional 50,626 shares during the last quarter. Bank of New York Mellon Corp increased its stake in CME Group by 2.9% in the 1st quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock valued at $1,462,678,000 after buying an additional 189,842 shares during the last quarter. Finally, Parnassus Investments LLC increased its stake in CME Group by 0.4% in the 4th quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock valued at $1,193,551,000 after buying an additional 23,583 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insiders Place Their Bets

In other news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Daniel R. Glickman sold 650 shares of CME Group stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the sale, the director now owns 14,008 shares of the company’s stock, valued at approximately $2,821,771.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now directly owns 7,163 shares in the company, valued at approximately $1,399,936.72. The disclosure for this sale can be found here. Insiders have sold a total of 54,290 shares of company stock valued at $11,393,700 in the last quarter. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of CME Group stock traded up $2.22 on Thursday, hitting $195.80. 4,568,618 shares of the company traded hands, compared to its average volume of 1,960,346. The firm’s 50-day simple moving average is $202.67 and its 200 day simple moving average is $207.71. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The company has a market cap of $70.50 billion, a P/E ratio of 22.43, a P/E/G ratio of 5.15 and a beta of 0.52. CME Group Inc. has a 12-month low of $180.11 and a 12-month high of $223.80.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.44 by $0.06. The firm had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The business’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the company posted $2.42 EPS. Analysts expect that CME Group Inc. will post 9.74 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Friday, June 7th were issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.35%. The ex-dividend date was Friday, June 7th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the stock. Rosenblatt Securities reissued a “sell” rating and set a $187.00 target price (up from $185.00) on shares of CME Group in a research report on Thursday, April 25th. Bank of America increased their target price on shares of CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a research report on Thursday, April 25th. JPMorgan Chase & Co. downgraded shares of CME Group from a “neutral” rating to an “underweight” rating and reduced their target price for the company from $206.00 to $187.00 in a research report on Friday, June 21st. Morgan Stanley increased their target price on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 9th. Finally, Keefe, Bruyette & Woods reissued a “market perform” rating and set a $226.00 target price on shares of CME Group in a research report on Wednesday, July 3rd. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $215.82.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.